Metabolism - Clinical and Experimental
Volume 54, Issue 5, Supplement , Pages 45-48 , May 2005

Depression and cardiovascular disease: a reciprocal relationship

References 

  1. Plante GE, Lehmann HE. Psycho-physiopathologie de la schizophrénie. Montr Med. 1963;15:23–30
  2. Prosser CL. Circulation of body fluids. In:  Prosser CL,  Brown FA editor. Comparative animal physiology. 2nd ed.. Philadephia: WB Saunders Co.; 1961;p. 386–416
  3. Sjostrand T. Volume and distribution of blood and their significance in regulating the circulation. Physiol Rev. 1953;33:202–257
  4. Reiff M, Schwartz S, Northridge M. Relationship of depressive symptoms to hypertension in a household survey in Harlem. Psychosom Med. 2001;63:711–721
  5. Dimsdale JE. Symptoms of anxiety and depression as precursor of hypertension. JAMA. 1997;277:574–575
  6. Shinn EH, Poston WS, Kimball KT, et al. Blood pressure and symptoms of depression and anxiety: a prospective study. Am J Hypertens. 2001;14:660–664
  7. Abramson J, Berger A, Krumholz HM, et al. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med. 2001;161:1725–1730
  8. Ariyo AA, Haan M, Tangen CM, et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation. 2000;102:1773–1779
  9. Davidson K, Jonas BS, Dixon KE, et al. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Coronary artery risk development in young adults. Arch Intern Med. 2000;160:1495–1500
  10. Wood WG, Elias MF, Schultz NR, et al. Anxiety and depression in young and middle aged hypertensive and normotensive subjects. Exp Aging Res. 1979;5:15–30
  11. Penninx BW, Guralnik JM, Mendes de Leon CF, et al. Cardiovascular events and mortality in newly and chronically depressed persons > 70 years of age. Am J Cardiol. 1998;81:988–994
  12. Dimsdale JE. Symptoms of anxiety and depression as precursors to hypertension. JAMA. 1997;277:574–575
  13. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000;140(Suppl. 4):77–83
  14. Thayer JF, Smith M, Rossy LA, et al. Heart period variability and depressive symptoms: gender differences. Biol Psychiatry. 1998;44:304–306
  15. Agelink MW, Boz C, Ullrich H, et al. Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Res. 2002;113:139–149
  16. Krittayaphong R, Cascio WE, Light KC, et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med. 1997;59:231–235
  17. Witton K. Circulatory lability and depression. J Am Geriatr Soc. 1966;14:1081–1084
  18. Watanabe T, Matsuura T, Watanabe M, et al. The relationship between ambulatory blood pressure variation and symptoms of depression and sleep disturbance in community-dwelling elderly persons with independent activities of daily living. Jpn J Public Health. 2002;49:178–187
  19. Leineweber C, Kecklund G, Janszky I, et al. Poor sleep increases the prospective risk for recurrent events in middle-aged women with coronary disease. The Stockholm female coronary risk study. J Psychosom Res. 2003;54:121–127
  20. Davies SJ, Ghahramani P, Jackson PR, et al. Panic disorder, anxiety and depression in resistant hypertension—a case control study. J Hypertens. 1997;15:1077–1082
  21. Ravaja N, Kauppinen T, Keltikangas-Jarvinen L. Relationships between hostility and physiological coronary heart disease risk factors in young adults: the moderating influence of depressive tendencies. Psychol Med. 2000;30:381–393
  22. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol. 2000;86:41F–45F
  23. Jones-Webb R, Jacobs DR, Flack JM, et al. Relationships between depressive symptoms, anxiety, alcohol consumption, and blood pressure: results from the CARDIA Study. Coronary artery risk development inn young adults study. Alcohol Clin Exp Res. 1996;20:420–427
  24. Kinder LS, Kamarck TW, Baum A, et al. Depressive symptomatology and coronary heart disease in type I diabetes mellitus: a study of possible mechanisms. Health Psychol. 2002;21:542–552
  25. Wassertheil-Smoller S, Applegate WB, Berge K, et al. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the elderly). Arch Intern Med. 1996;156:553–561
  26. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med. 2002;23:51–61
  27. Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001;104:2024–2028
  28. Rudolf GA, Bischofs W, Blaszkiewicz F, et al. Circulatory function in depression with the circadian rhythm uninfluenced or modified. Arzneimittelforschung. 1976;26:1174–1177
  29. Boivin DB, Czeisler CA, Dijk DJ. Complex interaction of the sleep-wake cycle and circadian phase modulates mood in healthy subjects. Arch Gen Psychiatry. 1997;45:145–152
  30. Dion D, Labrecque G, Plante GE. Variations saisonnières de la perméabilité endothéliale à l'albumine chez le rat normal anesthésié. Med Sci. 2001;17(Suppl. 1):22
  31. Et-Taouil K, Schiavi PI, Levy B, et al. Sodium intake, large artery matrix composition and compliance in the SHR. Hypertension. 2001;38:1172–1176
  32. Plante GE. Vascular effects of stress in health and disease. Metabolism. 2002;15(Suppl. 1):25–30
  33. Kunugimoto N, Yamasaki K. The effects of hostility on blood pressure and depression: role of conscious defensiveness. Jpn J Psychol. 2003;74:171–177
  34. Bichoy HG, Sirois P. Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice. Eur J Pharmacol. 2002;457:115–124
  35. Taylor BK, Roderick RE, St Lezin E, et al. Hypoalgesia and hyperalgesia with inherited hypertension in the rat. Am J Physiol. 2001;280:R345–R354
  36. DiBona GF, Sawin LL. Effect of arterial baroreceptor denervation on sodium balance. Hypertension. 2002;40:547–551
  37. Et-Taouil K, Safar M, Plante GE. Mechanisms and consequences of large artery rigidity. Can J Physiol Pharmacol. 2003;81:205–211
  38. Gotthardt U, Schweiger U, Fahrenberg J, et al. Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression. Am J Physiol. 1995;268:R865–R873
  39. Kop WJ, Gottdiener JS, Tangen CM, et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002;89:419–424
  40. Christensen NJ. Adrenergic mechanisms in selected diseases: arterial hypertension, duodenal ulcer, primary depressive illness, malignant tumors, and ketotic hypoglycemia. Metabolism. 1980;29(11 Suppl. 1):1190–1197
  41. Louis WJ, Doyle AE, Anavekar SN. Plasma noradrenaline concentration and blood pressure in essential hypertension, phechromocytoma and depression. Clin Sci Mol Med. 1975;2:S239–S242
  42. Shimbo D, Child J, Davidson K, et al. Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol. 2002;89:331–333
  43. Sheline YI, Freedland KE, Carney RM. How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?. Am J Med. 1997;102:54–59
  44. Serebruany VL, Glassman AH, Malinin AI, et al. Sertraline Antidepressant Heart Attack Randomized Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy. Circulation. 2003;108:939–944
  45. Severus WE, Littman AB, Stoll AL. Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry. 2001;9:280–293
  46. Markovich D. Physiological roles and regulation of mammalian sulfate transporters. Physiol Rev. 2001;81:1499–1533
  47. Plante GE, Chakir M, Lehoux S, et al. Disorders of body fluid balance: a new look into the mechanisms of disease. Can J Cardiol. 1995;11:788–802
  48. Kumar A, Thomas A, Lavretsky H, et al. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry. 2002;159:630–636
  49. Steffens DC, Krishnan KRR, Crump C, et al. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke. 2002;33:1636–1644

PII: S0026-0495(05)00035-1

doi: 10.1016/j.metabol.2005.01.013

Metabolism - Clinical and Experimental
Volume 54, Issue 5, Supplement , Pages 45-48 , May 2005

Article Tools